The prepubertal testis: Biomarkers and functions

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 3, 2013, Pages 224-233

  Valeri, Clara ^a   Schteingart, Helena F ^a   Rey, Rodolfo A ^a,b  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Bisphenol A; Disorders of sex development; Gonadotropins; Phthalates; Testicular dysgenesis

Indexed keywords

ANDROGEN RECEPTOR; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; INHIBIN B; MUELLERIAN INHIBITING FACTOR; RELAXIN 3; TESTOSTERONE;

CANCER THERAPY; CRYPTORCHISM; DOWN SYNDROME; GONADAL DYSGENESIS; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; KLINEFELTER SYNDROME; LEUKEMIA; MALE INFERTILITY; NOONAN SYNDROME; ONTOGENY; PRADER WILLI SYNDROME; PREMATURITY; PREPUBERTY; PROTEIN EXPRESSION; REVIEW; SERTOLI CELL; SMALL FOR DATE INFANT; TESTIS FUNCTION;

ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CHILD; CHILD DEVELOPMENT; DISORDERS OF SEX DEVELOPMENT; HUMANS; INFANT; INHIBINS; INSULIN; LEYDIG CELLS; MALE; PROTEINS; SERTOLI CELLS; SPERMATOGENESIS; TESTIS;

EID: 84879204993     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328360be2c     Document Type: Review

References (90)

1. Josso N, Rey R, Picard JY. Testicular anti-Mullerian hormone: clinical applications in DSD. Semin Reprod Med 2012; 30:364-373.
2. Rey RA, Grinspon RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2011; 25:221-238.
3. Welsh M, Saunders PT, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008; 118:1479-1490. (Pubitemid 351500441)
4. Bay K, Andersson AM. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Int J Androl 2011; 34:97-109.
5. Ivell R, Anand-Ivell R. Biological role and clinical significance of insulin-like peptide 3. Curr Opin Endocrinol Diabetes Obes 2011; 18:210-216.
6. Lasala C, Schteingart HF, Arouche N, et al. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Müllerian gene expression in the testicular prepubertal Sertoli cell line SMAT1. Am J Physiol Endocrinol Metab 2011; 301:E539-E547.
7. Grinspon RP, Loreti N, Braslavsky D, et al. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab 2012; 25:3- 11.
8. Bergadá I, Milani C, Bedecarra's P, et al. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006; 91:4092-4098. (Pubitemid 44536890)
9. Forest MG, Sizonenko PC, Cathiard AM, Bertrand J. Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 1974; 53:819-828.
10. Kuiri-Hanninen T, Seuri R, Tyrvainen E, et al. Increased activity of the hypothalamic-pituitary-testicular axis in infancy results in increased androgen action in premature boys. J Clin Endocrinol Metab 2011; 96:98-105.
11. Aksglæde L, Sorensen K, Boas M, et al. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010; 95:5357-5364.
12. Grinspon RP, Bedecarrás P, Ballerini MG, et al. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. Int J Androl 2011; 34:e487-e498.
13. Bergadá I, Rojas G, Ropelato MG, et al. Sexual dimorphism in circulating monomeric and dimeric inhibins in normal boys and girls from birth to puberty. Clin Endocrinol 1999; 51:455-460. (Pubitemid 29513312)
14. Grinspon RP, Ropelato MG, Bedecarra's P, et al. Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness. Clin Endocrinol (Oxf) 2012; 76:698- 705.
15. Pasqualini T, Chemes H, Rivarola MA. Testicular testosterone levels during puberty in cryptorchidism. Clin Endocrinol 1981; 15:545-554. (Pubitemid 12253554)
16. Page ST. Physiologic role and regulation of intratesticular sex steroids. Curr Opin Endocrinol Diabetes Obes 2011; 18:217-223.
17. Ferlin A, Garolla A, Rigon F, et al. Changes in serum insulin-like factor 3 during normal male puberty. J Clin Endocrinol Metab 2006; 91:3426-3431. (Pubitemid 44402114)
18. Chemes HE, Rey RA, Nistal M, et al. Physiologic androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab 2008; 93:4408-4412. (Pubitemid 352789539)
19. Boukari K, Meduri G, Brailly-Tabard S, et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Müllerian hormone repression during early human testis development. J Clin Endocrinol Metab 2009; 94:1818-1825.
20. Berensztein EB, Baquedano MS, Gonzalez CR, et al. Expression of aromatase, estrogen receptor alpha and beta, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatr Res 2006; 60:740- 744. (Pubitemid 44789519)
21. Anand-Ivell RJ, Relan V, Balvers M, et al. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 2006; 74:945-953.
22. Chemes HE, Dym M, Raj HG. Hormonal regulation of Sertoli cell differentiation. Biol Reprod 1979; 21:251-262. (Pubitemid 9249750)
23. Willems A, Batlouni SR, Esnal A, et al. Selective ablation of the androgen receptor in mouse Sertoli cells affects Sertoli cell maturation, barrier formation and cytoskeletal development. PLoS ONE 2010; 5:e14168.
24. Pelletier RM. The blood-testis barrier: the junctional permeability, the proteins and the lipids. Prog Histochem Cytochem 2011; 46:49-127.
25. Cheng CY, Mruk DD. The blood-testis barrier and its implications for male contraception. Pharmacol Rev 2012; 64:16-64.
26. Josso N, Picard JY, Rey R, Clemente N. testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 2006; 3:347-358. (Pubitemid 44014045)
27. De Gendt K, Swinnen JV, Saunders PTK, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci U S A 2004; 101:1327-1332. (Pubitemid 38182688)
28. Rey RA, Musse M, Venara M, Chemes HE. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech 2009; 72:787-795.
29. Grinspon R, Chemes H, Rey RA. Decline in serum antimüllerian hormone due to androgen action in early puberty in males. Fertil Steril 2012; 98:e23.
30. Grinspon RP, Rey RA. Antimüllerian hormone and Sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr 2010; 73:81-92.
31. Berger T, Conley AJ, Van Klompenberg M, et al. Increased testicular Sertoli cell population induced by an estrogen receptor antagonist. Mol Cell Endocrinol 2013; 366:53-58.
32. Belgorosky A, Guercio G, Pepe C, et al. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. Horm Res 2009; 72:321-330.
33. Young J, Chanson P, Salenave S, et al. Testicular antimullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90:724- 728. (Pubitemid 40279186)
34. Bougnères P, François M, Pantalone L, et al. Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. J Clin Endocrinol Metab 2008; 93:2202-2205. (Pubitemid 351831536)
35. Grinspon RP, Ropelato MG, Gottlieb S, et al. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2010; 95:2811-2818.
36. Rey RA, Grinspon RP, Gottlieb S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology 2013; 1:3-16.
37. Bastida MG, Rey RA, Bergadá I, et al. Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome. Clin Endocrinol 2007; 67:863-870. (Pubitemid 350135129)
38. Cabrol S, Ross JL, Fennoy I, et al. Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels. J Clin Endocrinol Metab 2011; 96:E746-E753.
39. Vorona E, Zitzmann M, Gromoll J, et al. Clinical, endocrinological, and epigenetic features of the 46, XX male syndrome, compared with 47, XXY Klinefelter patients. J Clin Endocrinol Metab 2007; 92:3458-3465. (Pubitemid 47435320)
40. Aksglæde L, Jensen RB, Carlsen E, et al. Increased basal and pulsatile secretion of FSH and LH in young men with 47, XXY or 46, XX karyotypes. Eur J Endocrinol 2008; 158:803-810. (Pubitemid 351837368)
41. Mendonca BB, Costa EMF, Belgorosky A, et al. 46, XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Metab 2010; 24:243- 262.
42. Grumbach MM. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 2005; 90:3122-3127. (Pubitemid 40686373)
43. Adan L, Lechevalier P, Couto-Silva AC, et al. Plasma inhibin B and antimullerian hormone concentrations in boys: Discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay. Med Sci Monit 2010; 16:CR511-CR517.
44. Coutant R, Biette-Demeneix E, Bouvattier C, et al. Baseline inhibin B and antimullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab 2010; 95:5225-5232.
45. Bergadá I, Andreone L, Bedecarra's P, et al. Seminiferous tubule function in delayed-onset X-linked adrenal hypoplasia congenita associated with incomplete hypogonadotrophic hypogonadism. Clin Endocrinol 2008; 68:240- 246.
46. Krawczuk-Rybak M, Plonowski M, Solarz E, et al. Assessment of gonadal function in boys and adolescents at the diagnosis of neoplastic disease. J Pediatr Endocrinol Metab 2012; 25:453-458.
47. Jahnukainen K, Ehmcke J, Hou M, Schlatt S. Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab 2011; 25:287-302.
48. Krawczuk-Rybak M, Solarz E, Wysocka J, et al. Testicular function after treatment for acute lymphoblastic leukemia (ALL) in prepubertal and pubertal boys. Pediatr Hematol Oncol 2009; 26:504-514.
49. Cuny A, Trivin C, Brailly-Tabard S, et al. Inhibin B and antimüllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. The Journal of Pediatrics 2011; 158:1016-1022.
50. Laporte S, Couto-Silva AC, Trabado S, et al. Inhibin B and anti-Mullerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr 2011; 11:20.
51. Karlberg S, Toppari J, Karlberg N, et al. Testicular failure and male infertility in the monogenic Mulibrey nanism disorder. J Clin Endocrinol Metab 2011; 96:3399-3407.
52. Ankarberg-Lindgren C, Westphal O, Dahlgren J. Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study. Eur J Endocrinol 2011; 165:137-144.
53. Radicioni AF, Di GG, Grugni G, et al. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2012; 76:72-77.
54. Hirsch HJ, Eldar-Geva T, Benarroch F, et al. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 2009; 94:2262-2268.
55. Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, et al. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 2012; 97:E452-E459.
56. Eiholzer U, l'Allemand D, Rousson V, et al. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart- Willi Syndrome. J Clin Endocrinol Metab 2006; 91:892-898. (Pubitemid 43357755)
57. Jensen RB, Vielwerth S, Larsen T, et al. Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction. J Clin Endocrinol Metab 2007; 92:1353- 1357. (Pubitemid 46556409)
58. Boonstra VH, Weber RF, de Jong FH, Hokken-Koelega AC. Testis function in prepubertal boys and young men born small for gestational age. Horm Res 2008; 70:357-363.
59. Mau Kai C, Main KM, Andersen AN, et al. Reduced serum testosterone levels in infant boys conceived by intracytoplasmic sperm injection. J Clin Endocrinol Metab 2007; 92:2598-2603. (Pubitemid 47037363)
60. Ceelen M, van Weissenbruch MM, Vermeiden JPW, et al. Pubertal development in children and adolescents born after IVF and spontaneous conception. Hum Reprod 2008; 23:2791-2798.
61. De Schepper J, Belva F, Schiettecatte J, et al. Testicular growth and tubular function in prepubertal boys conceived by intracytoplasmic sperm injection. Horm Res 2009; 71:359-363.
62. Belva F, Bonduelle M, Painter RC, et al. Serum inhibin B concentrations in pubertal boys conceived by ICSI: first results. Hum Reprod 2010; 25:2811- 2814.
63. Ferlin A, Zuccarello D, Zuccarello B, et al. Genetic alterations associated with cryptorchidism. JAMA 2008; 300:2271-2276.
64. Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update 2008; 14:49-58.
65. Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 2002; 87:3598-3602. (Pubitemid 34879501)
66. Suomi AM, Main KM, Kaleva M, et al. Hormonal changes in 3-month-old cryptorchid boys. J Clin Endocrinol Metab 2006; 91:953-958. (Pubitemid 43357764)
67. Gaudino R, Cavarzere P, Camilot M, et al. Prepubertal serum inhibin B in cryptorchid infants and in monorchid boys with compensatory testicular hypertrophy. Fertil Steril 2008; 90:2217-2221.
68. Bay K, Virtanen HE, Hartung S, et al. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitarygonadal axis activation, and cryptorchidism. J Clin Endocrinol Metab 2007; 92:4020-4027. (Pubitemid 47607655)
69. Kollin C, Stukenborg JB, Nurmio M, et al. Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab 2012; 97:4588-4595.
70. Rey RA. Early orchiopexy to prevent germ cell loss during infancy in congenital cryptorchidism. J Clin Endocrinol Metab 2012; 97:4358-4361.
71. Hadziselimovic F, Hocht B, Herzog B, Buser MW. Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 2007; 68:46-52. (Pubitemid 46878360)
72. Main KM, Skakkebæk NE, Virtanen HE, Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010; 24:279- 289.
73. Sharpe RM. The 'oestrogen hypothesis': where do we stand now? Int J Androl 2003; 26:2-15. (Pubitemid 36110849)
74. Wilcox AJ, Baird DD, Weinberg CR, et al. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995; 332:1411-1416.
75. Sharpe RM. Additional effects of phthalate mixtures on fetal testosterone production. Toxicol Sci 2008; 105:1-4.
76. Meeker JD. Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med 2012; 166:E1-E7.
77. Lambrot R, Muczynski V, Lecureuil C, et al. Phthalates impair germ cell development in the human fetal testis in vitro without change in testosterone production. Environ Health Perspect 2009; 117:32-37.
78. Chauvigné F, Menuet A, Lesné L, et al. Time- and dose-related effects of di- (2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro. Environ Health Perspect 2009; 117:515-521.
79. Chauvigné F, Plummer S, Lesné L, et al. Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. PLoS ONE 2011; 6:e27172.
80. Desdoits-Lethimonier C, Albert O, Le BB, et al. Human testis steroidogenesis is inhibited by phthalates. Hum Reprod 2012; 27:1451-1459.
81. Muczynski V, Cravedi JP, Lehraiki A, et al. Effect of mono-(2-ethylhexyl) phthalate on human and mouse fetal testis: In vitro and in vivo approaches. Toxicol Appl Pharmacol 2012; 261:97-104.
82. Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 2008; 108:177- 184.
83. Suzuki Y, Yoshinaga J, Mizumoto Y, et al. Foetal exposure to phthalate esters and anogenital distance in male newborns. Int J Androl 2012; 35:236-244.
84. Main KM, Mortensen GK, Kaleva MM, et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 2006; 114:270- 276. (Pubitemid 43193651)
85. Ye L, Zhao B, Hu G, et al. Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A. Toxicol Lett 2011; 207:137-142.
86. Gualtieri AF, Iwachow MA, Venara M, et al. Bisphenol A effect on glutathione synthesis and recycling in testicular Sertoli cells. J Endocrinol Invest 2011; 34:e102-e109.
87. Chevalier N, Vega A, Bouskine A, et al. GPR30, the Non-Classical Membrane GProtein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation. PLoS ONE 2012; 7:e34672.
88. Andersen HR, Bonefeld-Jørgensen EC, Nielsen F, et al. Estrogenic effects in vitro and in vivo of the fungicide fenarimol. Toxicol Lett 2006; 163:142-152.
89. Orton F, Rosivatz E, Scholze M, Kortenkamp A. Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. Environ Health Perspect 2011; 119:794-800.
90. Wohlfahrt-Veje C, Andersen HR, Jensen TK, et al. Smaller genitals at school age in boys whose mothers were exposed to nonpersistent pesticides in early pregnancy. Int J Androl 2012; 35:265-272. Técnicas Tecnológica